- Home
- IOBT vs PTHL Comparison
IOBT vs PTHL Comparison
Compare IOBT & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- PTHL
- Stock Information
- Founded
- IOBT 2014
- PTHL 1998
- Country
- IOBT Denmark
- PTHL China
- Employees
- IOBT N/A
- PTHL N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- PTHL
- Sector
- IOBT Health Care
- PTHL
- Exchange
- IOBT Nasdaq
- PTHL Nasdaq
- Market Cap
- IOBT 79.7M
- PTHL 85.4M
- IPO Year
- IOBT 2021
- PTHL 2024
- Fundamental
- Price
- IOBT $1.29
- PTHL $19.19
- Analyst Decision
- IOBT Strong Buy
- PTHL
- Analyst Count
- IOBT 3
- PTHL 0
- Target Price
- IOBT $9.33
- PTHL N/A
- AVG Volume (30 Days)
- IOBT 233.4K
- PTHL 924.8K
- Earning Date
- IOBT 08-12-2025
- PTHL 02-11-2025
- Dividend Yield
- IOBT N/A
- PTHL N/A
- EPS Growth
- IOBT N/A
- PTHL N/A
- EPS
- IOBT N/A
- PTHL N/A
- Revenue
- IOBT N/A
- PTHL $448,196.00
- Revenue This Year
- IOBT N/A
- PTHL N/A
- Revenue Next Year
- IOBT N/A
- PTHL N/A
- P/E Ratio
- IOBT N/A
- PTHL N/A
- Revenue Growth
- IOBT N/A
- PTHL N/A
- 52 Week Low
- IOBT $0.66
- PTHL $1.32
- 52 Week High
- IOBT $1.73
- PTHL $19.47
- Technical
- Relative Strength Index (RSI)
- IOBT 49.63
- PTHL N/A
- Support Level
- IOBT $1.26
- PTHL N/A
- Resistance Level
- IOBT $1.57
- PTHL N/A
- Average True Range (ATR)
- IOBT 0.13
- PTHL 0.00
- MACD
- IOBT -0.04
- PTHL 0.00
- Stochastic Oscillator
- IOBT 19.46
- PTHL 0.00
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.